Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Oncology

Latest News

December 17th 2018

Report Assesses Degree of Alignment Between ASCO, ESMO Oncology Frameworks

By Allison Inserro

A joint assessment comparing the results of value frameworks created by the American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO) found that the frameworks produce comparable measures of the clinical benefits of new cancer therapies in roughly two-thirds of more than 100 drug comparisons examined.

December 16th 2018

Common Factors Among Successful Practices in the OCM

By Laura Joszt, MA

December 16th 2018

Podcast: This Week in Managed Care—US Uninsured Rate Increases and Other Health News

December 14th 2018

Using Cost Variation to Identify Savings Opportunities Under the OCM

December 13th 2018

Equity in Cancer Care: A Viewpoint From Patient Advocates

By Jaime Rosenberg

Latest Videos

Transplant Patients' Options, CoMMpass Study, and Doublet Versus Triplet Therapy

Transplant Patients' Options, CoMMpass Study, and Doublet Versus Triplet Therapy

Dr Robert Daly Discusses How Clinical Pathways Can Reduce Disparities in Breast Cancer

Dr Robert Daly Discusses How Clinical Pathways Can Reduce Disparities in Breast Cancer

Dr Barbara McAneny Explains the Current Focus of Care Management in Oncology

Dr Barbara McAneny Explains the Current Focus of Care Management in Oncology

Dr Michael Kolodziej Reflects on OCM and What Might Come After

Dr Michael Kolodziej Reflects on OCM and What Might Come After

Dr Sibel Blau Discusses Physician, Staff Education Around OCM

Dr Sibel Blau Discusses Physician, Staff Education Around OCM

Dr Robert Daly Explains the Importance of Updating Pathways With New Data

Dr Robert Daly Explains the Importance of Updating Pathways With New Data

Beth Wittmer Discusses Diet Restrictions With Neutropenia

Beth Wittmer Discusses Diet Restrictions With Neutropenia

This Week in Managed Care: December 14, 2018

This Week in Managed Care: December 14, 2018

Adherence With CDK4/6 Inhibitors

Adherence With CDK4/6 Inhibitors

Patient Management of CDK4/6 Inhibitors

Patient Management of CDK4/6 Inhibitors

More News

Dispensing of CDK4/6 Inhibitors

December 12th 2018

Multidisciplinary Approach: Managing CDK4/6 Inhibitors

December 12th 2018

Patients' Perspectives on CDK4/6 Inhibitors

December 12th 2018

Benefits and Challenges of CDK4/6 Inhibitors

December 12th 2018

Metastatic Breast Cancer: CDK4/6 Inhibitors

December 12th 2018

Improving Care for Patients With Metastatic Breast Cancer

December 12th 2018

Educating Patients and Staff on Using CDK4/6 Inhibitors

December 12th 2018

Best Practices for Managing Patients on CDK4/6 Inhibitors

December 12th 2018

Multidisciplinary Care in Breast Cancer

December 12th 2018

Considerations for Treating Patients with CDK4/6 Inhibitors

December 12th 2018

CDK4/6 Inhibitors in Metastatic Breast Cancer

December 12th 2018

Medically Integrated Pharmacy Teams Spur Innovations

December 12th 2018

Oral Oncolytics and Patient Adherence

December 12th 2018

Medically Integrated Dispensing Service Best Practices

December 12th 2018

Practical Challenges in Switching to CDK4/6 Inhibitors

December 12th 2018

The Efficacy and Safety of CDK4/6 Inhibitors

December 12th 2018

Roles of the Oncologist Versus Pharmacist

December 12th 2018

Multidisciplinary Approach to Managing Oral Oncolytics

December 12th 2018

The Advent of Oral Oncolytics and Patient Access

December 12th 2018

From the Editor-in-Chief: Why the Future Never Arrives

ByJoseph Alvarnas, MD

December 12th 2018

Biosimilars Updates

ByKelly Davio,Samantha DiGrande

December 12th 2018

Medical World News: Regulatory Updates

By

December 12th 2018

Medical World News: Clinical Updates

By

December 12th 2018

Medical World News: Managed Care Updates, December 11, 2018

ByMary Caffrey,Allison Inserro,Laura Joszt, MA,David Bai, PharmD,Samantha DiGrande

December 11th 2018

Cost Variation and Savings Opportunities in the Oncology Care Model

ByJames Baumgardner, PhD,Ahva Shahabi, PhD,Christopher Zacker, RPh, PhD,Darius Lakdawalla, PhD

December 11th 2018

Geographic variation in cancer treatment spending reveals that chemotherapy and hospital inpatient care may offer opportunities for savings for practices participating in the Oncology Care Model.

Trending on AJMC

Three Years on Baricitinib Preserved Hair Regrowth in Severe Alopecia Areata

Oz White House Briefing Touts Drug Savings and Fraud Cleanup, but Data Tell a Nuanced Story

First Clinical Evidence of Gene Editing, Epigenetic Silencing of HBV cccDNA

5 Notable Oncology FDA Approvals Granted in May

Endometriosis Reduces Ovarian Reserve via Inflammation and Surgery